Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Principales indicadores del Programa de Diagnóstico Precoz del Cáncer Cervicouterino en un hospital de Santiago de Cuba. (Spanish)

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Alternate Title:
      Main indicators of the Early Diagnosis Program of Cervical Cancer in a Hospital in Santiago de Cuba. (English)
    • نبذة مختصرة :
      Introduction: Cervical cancer is the third leading cause of death from malignancies worldwide, affecting mainly low- and middle-income countries. By 2020 an incidence of 604,000 new cases was estimated. Objective: To characterize the main hospital indicators of the Cervical Cancer Early Diagnosis Program. Methods: An observational, descriptive and cross-sectional study was carried out to characterize the main hospital indicators of the Program in the Neck Pathology Service of the General Hospital Dr. Bruno Zayas Alfonso of Santiago de Cuba, from January 2020 to December 2022. The study population consisted of 443 women. The data collected were analyzed using descriptive statistic techniques, expressed in frequency and percentages. Results: Of the women studied, 60.9 %had cervical intraepithelial lesion of high degree of malignancy, with 32.6 % positive for cervical cancer. The overall percentage of useless cytological tests was 2.07 and no cells from the processing zone was 4.01, both quality indicators. There was a high significance in terms of the overall coverage rate of women at risk (K=0.615), showing that the results of the cytology largely reflect the diagnosis of histology, with a good agreement. Conclusions: Cervical-vaginal cytology remains the most valuable diagnostic method for detecting cervical intraepithelial neoplasm and early-stage carcinoma in large populations [ABSTRACT FROM AUTHOR]
    • نبذة مختصرة :
      Introducción: El ca ncer cervicouterino ocupa el tercer lugar como causa de defuncio n por neoplasias malignas a nivel mundial, afectando principalmente a los paí ses de ingresos bajos y medianos. Hacia el 2020 se estimo una incidencia de 604 000 nuevos casos. Objetivo: Caracterizar los principales indicadores hospitalarios del Programa de Diagno stico Precoz del Ca ncer Cervicouterino. Métodos: Se realizo un estudio observacional, descriptivo y transversal, que permitio caracterizar los principales indicadores hospitalarios del Programa en el Servicio de Patologí a de Cuello del Hospital General Dr. Juan Bruno Zayas Alfonso de Santiago de Cuba, de enero del 2020 a diciembre del 2022. La poblacio n de estudio estuvo constituida por 443 mujeres. Los datos recopilados fueron analizados mediante te cnicas de estadí stica descriptiva, expresa ndose en frecuencia y porcentajes. Resultados: De las mujeres estudiadas, 60,9 % presentaron lesio n intraepitelial cervical de alto grado de malignidad, con 32,6 % positivo a ca ncer cervicouterino. El porcentaje global de pruebas citolo gicas no u tiles fue de 2,07 y sin ce lulas de la zona de transformacio n, de 4,01; ambos indicadores de calidad. Existio una alta significacio n en cuanto a la tasa de cobertura global de las mujeres en riesgo (K=0,615), demostrando que los resultados de la citologí a reflejan en gran medida los diagno sticos de la histologí a, con una buena concordancia. Conclusiones: La prueba citolo gica ce rvico-vaginal sigue siendo el me todo diagno stico de mayor valor para detectar neoplasia intraepitelial cervical y carcinoma en estadio precoz en grandes masas de poblacio n. [ABSTRACT FROM AUTHOR]
    • نبذة مختصرة :
      Copyright of MEDISAN is the property of Centro Provincial de Informacion en Ciencias Medicas de Santiago de Cuba and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)